全球元基因組定序市場

預計到 2032 年，全球元基因組定序市場規模將達到 44 億美元。

全球元基因組定序市場規模預計在2025年為14億美元，在2025年至2032年的分析期間將以18.0%的複合年成長率成長，到2032年達到44億美元。本報告分析的細分市場之一—「試劑和耗材」細分市場，預計將以19.7%的複合年成長率成長，並在分析期結束時達到19億美元。 「儀器」細分市場預計在整個分析期間將以17.9%的複合年成長率成長。

美國市場規模估計為 4.256 億美元，而中國市場預計將以 24.2% 的複合年成長率成長。

美國元基因組定序市場預計到2025年將達到4.256億美元。作為世界第二大經濟體，中國預計在2025年至2032年的分析期間將以24.2%的複合年成長率成長，到2032年市場規模將達到12億美元。其他值得關注的區域市場包括日本和加拿大，預計在分析期內將分別以14.0%和17.1%的複合年成長率成長。在歐洲，德國預計將以約15.0%的複合年成長率成長。

全球元基因組定序市場—關鍵趨勢與促進因素概述

為什麼元基因組定序正在改變微生物組研究？

元基因組定序徹底革新了微生物組研究領域，它提供了一個強大的工具，可以直接從環境樣本分析整個微生物群落的遺傳物質。與需要培養單一微生物的傳統微生物學方法不同，元基因組定序使研究人員能夠全面研究複雜的微生物生態系統，例如人類腸道、土壤和海洋。這項技術對於加深我們對微生物多樣性和相互作用的理解，以及它們在人類健康、農業和環境永續性所發揮的作用至關重要。因此，元基因組定序現已廣泛應用於從醫學研究到生物技術和農業等眾多領域。

哪些創新正在塑造元基因組定序市場？

元基因組定序領域的創新主要集中在提高定序準確性、降低成本和拓展技術應用範圍。次世代定序（NGS）平台顯著降低了元基因組分析所需的成本和時間，使該技術更容易被各行各業的研究人員所採用。此外，機器學習演算法的整合透過識別先前未知的微生物物種並預測其在生態系統中的功能，增強了數據分析能力。單細胞基因體學和長讀長定序也正在成為極具前景的創新技術，能夠對單一生物體層次的微生物群落進行更詳細、更精確的分析。

市場區隔如何定義元基因組定序的成長？

應用領域包括人類健康與疾病研究、農業、環境監測和工業生物技術。其中，人類健康與疾病研究，特別是腸道微生物組分析和感染疾病檢測等領域，佔據了最大的市場佔有率，這主要得益於人們對微生物在人類健康中所扮演角色的日益關注。從技術層面來看，次世代定序目前佔據市場主導地位，但長讀長定序因其能夠提供更全面的數據而備受關注。終端使用者包括學術研究機構、製藥公司和政府機構，但學術機構由於對微生物生態學和人類健康研究的重視，成為市場的主要驅動力。

哪些因素推動了元基因組定序市場的成長？

元基因組定序市場的成長受多種因素驅動，包括人們對微生物組研究的日益關注、定序技術的進步以及在醫療和農業領域應用範圍的不斷擴大。人們對人類微生物組在健康和疾病中的作用認知不斷提高，推動了醫學研究對元基因組定序的需求。次世代定序和機器學習等技術的進步提高了微生物分析的速度和準確性，進一步加速了其應用。此外，該技術在永續農業、環境監測和工業生物技術等領域的廣泛應用也促進了市場成長。

部分：

組件（試劑和耗材、儀器、服務、分析和數據解釋解決方案）、技術（16S rRNA、鳥槍法測序、宏轉錄組學、全基因測序和從頭組裝）、應用（藥物發現、臨床診斷、土壤微生物組、工業和其他應用）

大公司

• BGI Group
• DNAStar, Inc.
• Eurofins Scientific
• GENEWIZ
• Illumina, Inc.
• IntegraGen SA
• Macrogen, Inc.
• Microsynth AG
• Novogene Corporation
• NuGEN Technologies, Inc.
• Oxford Nanopore Technologies Ltd.
• PerkinElmer
• QIAGEN NV
• Thermo Fisher Scientific, Inc.
• Zymo Research Corporation

目錄

第1章：調查方法

第2章執行摘要

• 市場概覽
• 大公司
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 澳洲
• 印度
• 韓國
• 亞太其他地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東國家
• 非洲

第4章 競賽

Global Metagenomic Sequencing Market to Reach US$4.4 Billion by 2032

The global market for Metagenomic Sequencing estimated at US$1.4 Billion in the year 2025, is expected to reach US$4.4 Billion by 2032, growing at a CAGR of 18.0% over the analysis period 2025-2032. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 19.7% CAGR and reach US$1.9 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 17.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$425.6 Million While China is Forecast to Grow at 24.2% CAGR

The Metagenomic Sequencing market in the U.S. is estimated at US$425.6 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2032 trailing a CAGR of 24.2% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.0% and 17.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.0% CAGR.

Global Metagenomic Sequencing Market - Key Trends and Drivers Summarized

Why Is Metagenomic Sequencing Transforming Microbiome Research?

Metagenomic sequencing has revolutionized the field of microbiome research, providing a powerful tool for analyzing genetic material from entire microbial communities directly from environmental samples. Unlike traditional microbiological methods, which require culturing individual organisms, metagenomic sequencing enables researchers to study complex microbial ecosystems, such as the human gut, soil, or oceans, in their entirety. This technology has become essential for advancing our understanding of microbial diversity, interactions, and their roles in human health, agriculture, and environmental sustainability. As a result, metagenomic sequencing is now widely used in fields ranging from medical research to biotechnology and agriculture.

What Innovations Are Shaping the Metagenomic Sequencing Market?

Innovations in metagenomic sequencing focus on improving sequencing accuracy, reducing costs, and expanding the technology's applications. Next-generation sequencing (NGS) platforms have significantly lowered the cost and time required for metagenomic analysis, making the technology more accessible to researchers across various industries. Additionally, the integration of machine learning algorithms is enhancing data analysis by identifying previously unknown microbial species and predicting their functions within ecosystems. Single-cell genomics and long-read sequencing are also emerging as promising innovations, allowing for more detailed and accurate analysis of microbial communities at the individual organism level.

How Do Market Segments Define the Growth of Metagenomic Sequencing?

Applications include human health and disease research, agriculture, environmental monitoring, and industrial biotechnology. Human health and disease research, particularly in areas like gut microbiome analysis and infectious disease detection, represents the largest market segment due to the growing interest in the role of microbes in human health. Technologically, next-generation sequencing dominates the market, although long-read sequencing is gaining traction for its ability to provide more comprehensive data. End-users include academic research institutions, pharmaceutical companies, and government agencies, with academic institutions leading the market due to their focus on microbial ecology and human health research.

What Factors Are Driving the Growth in the Metagenomic Sequencing Market?

The growth in the metagenomic sequencing market is driven by several factors, including the increasing focus on microbiome research, advancements in sequencing technologies, and expanding applications in healthcare and agriculture. The growing recognition of the role of the human microbiome in health and disease is fueling demand for metagenomic sequencing in medical research. Technological advancements, such as next-generation sequencing and machine learning, are improving the speed and accuracy of microbial analysis, further driving adoption. Additionally, the technology’s applications in areas like sustainable agriculture, environmental monitoring, and industrial biotechnology are expanding, contributing to market growth.

SCOPE OF STUDY:

The report analyzes the Metagenomic Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Reagents & Consumables, Instruments, Services, Analysis & Data Interpretation Solutions); Technology (16S rRNA, Shotgun, Metatranscriptomics, Whole-Genome Sequencing & De Novo Assembly); Application (Drug Discovery, Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• BGI Group
• DNAStar, Inc.
• Eurofins Scientific
• GENEWIZ
• Illumina, Inc.
• IntegraGen SA
• Macrogen, Inc.
• Microsynth AG
• Novogene Corporation
• NuGEN Technologies, Inc.
• Oxford Nanopore Technologies Ltd.
• PerkinElmer
• QIAGEN N.V.
• Thermo Fisher Scientific, Inc.
• Zymo Research Corporation

WHAT SETS THIS REPORT APART FROM OTHERS?

Validated Sources - Human-curated validation and ranking of original source content, not AI LLM-generated synthetic content which dominates the internet today and has become a quick fix for most published research reports these days. Unlike most other published sources, our customers have access to full-stack source content. Our report draws from "real intelligence" balancing the power of AI against the risks of synthetically generated content and resulting biases. Customers have access to the source feeds.

Domain Expert Insights - Domain expert insights curated from enterprise, industry, academia, and government, consolidated from multilingual multimedia formats of text, voice, and images comprise a significant resource. Customers can request access to the pool of domain experts we track for this research project. We track 4,330 domain experts and their insights as part of this research project. Our customers may access our online tracker.

Annual subscription - Recommended for maximum value for your research dollar. Provides one additional full update during the 12 months and access to our research portal and interactive 10-user peer-to-peer collaboration drawing from our entire stack of validated project data which is updated on a weekly basis. Platform also enables adding enterprise data or third-party licensed content to build bespoke versions. Includes competitor tracking of up to 50 companies featured in the report.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Global Economic Update
  • Metagenomic Sequencing - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Advanced Genomic Solutions Spurs Growth in Metagenomic Sequencing Market
  • Technological Advancements in Next-Generation Sequencing (NGS) Strengthen Business Case for Adoption
  • Growing Focus on Microbiome Research and Pathogen Detection Expands Addressable Market for Metagenomic Sequencing
  • Expansion of Metagenomic Sequencing in Clinical Diagnostics and Drug Discovery Fuels Market Growth
  • Increasing Adoption of Metagenomic Sequencing in Agriculture and Environmental Studies Expands Market Opportunities
  • Technological Innovations in Data Analysis and Bioinformatics Tools Propel Market Expansion
  • Growing Use of Metagenomic Sequencing in Antimicrobial Resistance Studies Expands Market Potential
  • Focus on Enhancing Accuracy and Speed of Sequencing Platforms Strengthens Market Growth
  • Rising Adoption of Metagenomic Sequencing in Cancer Research and Immunotherapy Expands Addressable Market
  • Increasing Focus on Regulatory Compliance and Data Security in Genomic Studies Drives Adoption of Sequencing
  • Rising Demand for Metagenomic Sequencing in Food Safety and Public Health Monitoring Expands Market Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Metagenomic Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 2: World Historic Review for Metagenomic Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 3: World 13-Year Perspective for Metagenomic Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 5: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 6: World 13-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 9: World 13-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 10: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 12: World 13-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 13: World Recent Past, Current & Future Analysis for Analysis & Data Interpretation Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 14: World Historic Review for Analysis & Data Interpretation Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 15: World 13-Year Perspective for Analysis & Data Interpretation Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 16: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 17: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 18: World 13-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 19: World Recent Past, Current & Future Analysis for Soil Microbiome by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 20: World Historic Review for Soil Microbiome by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 21: World 13-Year Perspective for Soil Microbiome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 22: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 23: World Historic Review for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 24: World 13-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 27: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 28: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 29: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 30: World 13-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 31: World Recent Past, Current & Future Analysis for Shotgun by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 32: World Historic Review for Shotgun by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 33: World 13-Year Perspective for Shotgun by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 34: World Recent Past, Current & Future Analysis for 16S rRNA by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 35: World Historic Review for 16S rRNA by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 36: World 13-Year Perspective for 16S rRNA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 37: World Recent Past, Current & Future Analysis for Metatranscriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 38: World Historic Review for Metatranscriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 39: World 13-Year Perspective for Metatranscriptomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 40: World Recent Past, Current & Future Analysis for Whole-Genome Sequencing & De Novo Assembly by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 41: World Historic Review for Whole-Genome Sequencing & De Novo Assembly by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 42: World 13-Year Perspective for Whole-Genome Sequencing & De Novo Assembly by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 43: World Metagenomic Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032

III. MARKET ANALYSIS

• UNITED STATES
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 45: USA Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 46: USA 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 47: USA Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 48: USA Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 49: USA 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 50: USA Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 51: USA Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 52: USA 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 54: Canada Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 55: Canada 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 57: Canada Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 58: Canada 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 60: Canada Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 61: Canada 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• JAPAN
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 63: Japan Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 64: Japan 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 66: Japan Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 67: Japan 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 69: Japan Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 70: Japan 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• CHINA
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 72: China Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 73: China 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 74: China Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 75: China Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 76: China 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 77: China Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 78: China Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 79: China 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• EUROPE
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Metagenomic Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 81: Europe Historic Review for Metagenomic Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 82: Europe 13-Year Perspective for Metagenomic Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 84: Europe Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 85: Europe 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 87: Europe Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 88: Europe 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 90: Europe Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 91: Europe 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• FRANCE
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 93: France Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 94: France 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 95: France Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 96: France Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 97: France 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 98: France Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 99: France Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 100: France 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• GERMANY
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 102: Germany Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 103: Germany 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 105: Germany Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 106: Germany 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 108: Germany Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 109: Germany 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 111: Italy Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 112: Italy 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 114: Italy Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 115: Italy 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 117: Italy Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 118: Italy 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• UNITED KINGDOM
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 120: UK Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 121: UK 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 122: UK Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 123: UK Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 124: UK 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 125: UK Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 126: UK Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 127: UK 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 129: Spain Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 130: Spain 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 132: Spain Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 133: Spain 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 135: Spain Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 136: Spain 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 138: Russia Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 139: Russia 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 141: Russia Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 142: Russia 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 144: Russia Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 145: Russia 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 148: Rest of Europe 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 151: Rest of Europe 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 154: Rest of Europe 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• AUSTRALIA
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
• INDIA
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
• SOUTH KOREA
• REST OF ASIA-PACIFIC
• LATIN AMERICA
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • TABLE 155: Latin America Recent Past, Current & Future Analysis for Metagenomic Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 156: Latin America Historic Review for Metagenomic Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 157: Latin America 13-Year Perspective for Metagenomic Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • TABLE 158: Latin America Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 159: Latin America Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 160: Latin America 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 161: Latin America Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 162: Latin America Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 163: Latin America 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 164: Latin America Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 165: Latin America Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 166: Latin America 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• ARGENTINA
  • TABLE 167: Argentina Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 168: Argentina Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 169: Argentina 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 170: Argentina Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 171: Argentina Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 172: Argentina 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 173: Argentina Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 174: Argentina Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 175: Argentina 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• BRAZIL
  • TABLE 176: Brazil Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 177: Brazil Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 178: Brazil 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 179: Brazil Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 180: Brazil Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 181: Brazil 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 182: Brazil Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 183: Brazil Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 184: Brazil 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• MEXICO
  • TABLE 185: Mexico Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 186: Mexico Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 187: Mexico 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 188: Mexico Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 189: Mexico Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 190: Mexico 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 191: Mexico Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 192: Mexico Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 193: Mexico 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• REST OF LATIN AMERICA
  • TABLE 194: Rest of Latin America Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 195: Rest of Latin America Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 196: Rest of Latin America 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 197: Rest of Latin America Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 198: Rest of Latin America Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 199: Rest of Latin America 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 200: Rest of Latin America Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 201: Rest of Latin America Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 202: Rest of Latin America 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• MIDDLE EAST
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • TABLE 203: Middle East Recent Past, Current & Future Analysis for Metagenomic Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 204: Middle East Historic Review for Metagenomic Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 205: Middle East 13-Year Perspective for Metagenomic Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • TABLE 206: Middle East Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 207: Middle East Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 208: Middle East 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 209: Middle East Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 210: Middle East Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 211: Middle East 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 212: Middle East Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 213: Middle East Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 214: Middle East 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• IRAN
  • TABLE 215: Iran Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 216: Iran Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 217: Iran 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 218: Iran Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 219: Iran Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 220: Iran 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 221: Iran Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 222: Iran Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 223: Iran 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• ISRAEL
  • TABLE 224: Israel Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 225: Israel Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 226: Israel 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 227: Israel Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 228: Israel Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 229: Israel 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 230: Israel Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 231: Israel Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 232: Israel 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• SAUDI ARABIA
  • TABLE 233: Saudi Arabia Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 234: Saudi Arabia Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 235: Saudi Arabia 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 236: Saudi Arabia Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 237: Saudi Arabia Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 238: Saudi Arabia 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 239: Saudi Arabia Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 240: Saudi Arabia Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 241: Saudi Arabia 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• UNITED ARAB EMIRATES
  • TABLE 242: UAE Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 243: UAE Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 244: UAE 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 245: UAE Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 246: UAE Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 247: UAE 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 248: UAE Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 249: UAE Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 250: UAE 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• REST OF MIDDLE EAST
  • TABLE 251: Rest of Middle East Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 252: Rest of Middle East Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 253: Rest of Middle East 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 254: Rest of Middle East Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 255: Rest of Middle East Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 256: Rest of Middle East 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 257: Rest of Middle East Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 258: Rest of Middle East Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 259: Rest of Middle East 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032
• AFRICA
  • Metagenomic Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • TABLE 260: Africa Recent Past, Current & Future Analysis for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 261: Africa Historic Review for Metagenomic Sequencing by Component - Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 262: Africa 13-Year Perspective for Metagenomic Sequencing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments, Services and Analysis & Data Interpretation Solutions for the Years 2020, 2026 & 2032
  • TABLE 263: Africa Recent Past, Current & Future Analysis for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 264: Africa Historic Review for Metagenomic Sequencing by Application - Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 265: Africa 13-Year Perspective for Metagenomic Sequencing by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Soil Microbiome, Industrial, Other Applications and Drug Discovery for the Years 2020, 2026 & 2032
  • TABLE 266: Africa Recent Past, Current & Future Analysis for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 267: Africa Historic Review for Metagenomic Sequencing by Technology - 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 268: Africa 13-Year Perspective for Metagenomic Sequencing by Technology - Percentage Breakdown of Value Sales for 16S rRNA, Shotgun, Metatranscriptomics and Whole-Genome Sequencing & De Novo Assembly for the Years 2020, 2026 & 2032

IV. COMPETITION